ArticleBrain and behavior2026
After the Trip: A Qualitative Study of Healthy Individuals' Motor Experiences Following Different Doses of Psilocybin.
Article in Brain and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
introductionPsilocybin is a naturally occurring classic psychedelic associated with widespread changes in brain function and promising therapeutic outcomes in several neuropsychiatric disorders. Complementing these findings, qualitative studies following psilocybin administration have revealed diverse and highly individual effects across multiple domains of subjective experience. However, little is known about its impacts on individuals' subjective motor experiences. With the tendency of individuals to stay stationary during psilocybin's effects, investigating qualitative motor experiences following low-to-moderate doses of psilocybin may offer novel considerations regarding safety and quality of individuals' psychedelic experiences. We aimed to explore healthy individuals' subjective experiences after receiving three different doses of psilocybin and conducting motor activity.
methodsFollowing the study procedure previously published, semi-structured interviews were conducted with 12 participants who had completed sessions of motor tasks at different doses of psilocybin, which were then transcribed and thematically analyzed.
resultsFour major themes were developed, each containing sub-themes: two motor themes, (1) mixed motor messages, including altered motor coordination, control, speed, and reaction time; (2) interacting influences on motor performance, including dose-dependent effects; and two non-motor themes, (3) transcendence, altered consciousness, and transformative "mysticism"; and (4) dynamic and enhanced psychological and sensory experiences.
conclusionThis work contributes to a more comprehensive understanding of psilocybin's multifaceted effects and their relevance to safety, therapeutic potential and future research in motor disorders. The findings will inform a broader dose-finding study and the design of proposed research on psilocybin-assisted physiotherapy for refractory motor functional neurological disorder.
trial registrationANZCTR number: ACTRN12621000560897.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.